SG Americas Securities
UTMD icon

SG Americas Securities’s Utah Medical Products UTMD Stock Holding History

SG Americas Securities’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$113K Buy
+1,633
New +$109K ﹤0.01% 3065
2025
Q2 		– Sell
-3,227
Closed -$181K – 3629
2025
Q1 		$181K Buy
3,227
+675
+26% +$40.4K ﹤0.01% 2605
2024
Q4 		$157K Buy
+2,552
New +$165K ﹤0.01% 2375
2023
Q2 		– Sell
-1,402
Closed -$133K – 3203
2023
Q1 		$133K Buy
+1,402
New +$129K ﹤0.01% 2726
2021
Q4 		– Sell
-2,039
Closed -$189K – 3828
2021
Q3 		$189K Buy
+2,039
New +$180K ﹤0.01% 3271
2020
Q3 		– Sell
-2,042
Closed -$181K – 3478
2020
Q2 		$181K Buy
2,042
+686
+51% +$61.6K ﹤0.01% 2942
2020
Q1 		$128K Buy
+1,356
New +$126K ﹤0.01% 2815
2018
Q1 		– Sell
-2,326
Closed -$189K – 3561
2017
Q4 		$189K Buy
+2,326
New +$182K ﹤0.01% 2474
2017
Q2 		– Sell
-1,617
Closed -$101K – 3533
2017
Q1 		$101K Buy
+1,617
New +$102K ﹤0.01% 2987
2016
Q4 		– Sell
-1,771
Closed -$106K – 3475
2016
Q3 		$106K Buy
+1,771
New +$113K ﹤0.01% 3033
2014
Q4 		– Sell
-2,851
Closed -$139K – 3376
2014
Q3 		$139K Buy
+2,851
New +$145K ﹤0.01% 2198

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $158M AUM 42.05% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SG Americas Securities's UTMD Position: Q2 2026 in Review

SG Americas Securities opened a new position in Utah Medical Products (UTMD) in Q2 2026: 1,633 shares worth $113K. The stake represents ﹤0.01% of the portfolio and ranks #3065 among its holdings. This is a return to the name: SG Americas Securities previously reported a position in UTMD as recently as Q1 2025.

SG Americas Securities first reported a position in UTMD in Q3 2014 and has held it in 11 quarters since. The position peaked at $189K in Q3 2021. 114 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.

  • SG Americas Securities held 1,633 shares of Utah Medical Products worth $113K as of Q2 2026.
  • Utah Medical Products was a new SG Americas Securities position in Q2 2026.
  • Utah Medical Products made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #3065 holding.
  • SG Americas Securities first reported a position in Utah Medical Products in Q3 2014 and has held it in 11 quarters since.
  • SG Americas Securities's Utah Medical Products position peaked at $189K in Q3 2021.
  • 114 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.